Nantes
France
8
2022-08-04
8
2026-06-23
These are the the leading inventors for applications assigned to CYTUNE PHARMA:
CYTUNE PHARMA based in Nantes, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
IL-2/IL-15R BETA GAMMA AGONIST DOSING REGIMENS FOR TREATING CANCER OR INFECTIOUS DISEASES
#2 | 2021-05-20 β Patent 11,753,454 granted on 2023-09-12IL-15 and IL-15R\alpha sushi domain based immunocytokines
#3 | 2021-01-14 β Patent 12,060,407 granted on 2024-08-13IL-15/IL-15Ralpha based conjugates purification method
#4 | 2018-11-01 β Patent 10,899,816 granted on 2021-01-26IL-15 and IL-15RΞ± sushi domain based immunocytokines
#5 | 2017-03-02 β Patent 10,808,022 granted on 2020-10-20IL-15/IL-15Ralpha based conjugates purification method
#6 | 2016-11-03 β Patent 10,626,155 granted on 2020-04-21IL-15 and IL-15R\alpha sushi domain based immunocytokines
#7 | 2016-06-23 β Patent 11,273,204 granted on 2022-03-15IL-15 and IL-15RAPLHA sushi domain based immunocytokines
#8 | 2016-03-10 β Patent 11,401,312 granted on 2022-08-02Cytokine derived treatment with reduced vascular leak syndrome
Also check out Cytune Pharma's (Nantes, France) applicant profile with 11 patent applications submitted.
374197 β